Delivery Order SPE2DB24D1205-SPE2DB24FCUHJ
Award Date
9/4/24
Potential Completion Date
9/25/24
Potential Value
$7.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,370.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 120-count capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,242.15 firm fixed price contract is for the supply of 4,565,585,855 units of the prescription drug BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a...
This is a $7,242.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565190632 BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of August 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and...
The U.S. Defense Logistics Agency (DLA) awarded a $7,242.15 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565481010 - BRUKINSA 80 MG CAPSULE 120S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a $7,242.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 12, 2024. This contract is not set aside for any specific business type....
This is a $12,740.00 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of July 24, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a $6,370.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through July 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,242.15 firm fixed-price delivery order is for the medication BRUKINSA 80 MG CAPSULE 120S, with a completion date of November 6, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,568,105,568 units of the drug BRUKINSA 80 MG CAPSULE 120S, with a ceiling value of $6,370.00. The contract has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $19,110.00 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...